HealthTech Week 2017
 
Programme - MTANZ MedTech Forum - Tuesday 20 June

0730-0820

Registration Open                                                                                                                                                 Levene Foyer

Exhibition Open and Welcome Refreshments                                                                                                                        Upper NZI


0820-0830
Welcome and Opening by Master of Ceremonies
Steve Hamilton, Vento Consulting Ltd, Auckland, NZ



Health Economics
The landscape is changing for Medical Technology to be assessed for NZ Market entry by payers. Suppliers will be required to present more data establishing cost effectiveness and improved patient outcomes. What data will be required, what processes will be developed to manage market entry?

0830-0910
Fixing Healthcare; What will healthcare look like in 2050?
Shamubeel Eaqub, Chartered Financial Analyst, Sense. Partners, Auckland, NZ

0910-0940
Challenges to Healthcare Delivery
Dr Lee Mathias, Chair, Health Promotion Agency, Auckland, NZ 

0940-1010
PHARMAC's Approach to Device Evaluation
Carsten Schousboe, Senior Health Economist, PHARMAC, Wellington, NZ
 


The District Health Boards (DHB) Procurement Strategy was released in 2016. This Strategy heralds a new era of collective DHB procurement. The strategy supports the need to provide more clarity and reduce complexity in the procurement process. Suppliers are a critical stakeholder in collaborating with this DHB strategy. What does supplier management relationship mean? What does the operating model look like?

1010-1030
Dr Nigel Murray, Chief Executive, Waikato DHB, Hamilton, NZ 
 


1030-1100

Morning Tea and Exhibitor Networking                                                                                                                                           Upper NZI


Market Access
Medical technology is useless unless it reaches the patient. Market access for innovative medical technology that contributes to health care efficiencies needs to have a reliable path to assessment and funding. We need to ensure barriers are minimised to market access. A panel of CEOs from PHARMAC, NZ Health Partnerships, GS1 and Ministry of Business, Innovation and Employment (MBIE) will discuss and explore these issues.

1100-1200
Market Access Panel

Steffan Crausaz, Chief Executive, PHARMAC, Wellington, NZ
Megan Main, Chief Executive, NZ Health Partnerships, Auckland, NZ
Dr Peter Stevens, Chief Executive, GS1 New Zealand, Wellington, NZ
Mark Richards, All Government Procurement, MBIE, Wellington, NZ 
 


A panel of District Health Boards CEO's will be joined by international expertise to discuss access for innovative medical technology into hospitals, how the Ministry of Health Strategy is to be implemented and what value based healthcare means to them.

1200-1300
DHB Health Leaders Panel

Debbie Chin, Chief Executive, Capital and Coast DHB, Wellington, NZ
Ron Dunham, Chief Executive, Lakes DHB, Rotorua, NZ
Stella Ward, Executive Director Allied Health, West Coast and Canterbury DHB, Christchurch, NZ
Dr Peyvand Khaleghian, Managing Partner, Avicenna Partners Investment Company LLC, United Arab Emirates



1300-1400

Lunch and Exhibitor Networking                                                                                                                                                        Upper NZI


The Ministry of Health has released new information standards required for accurate and consistent description and identification of medical devices in NZ using internationally recognised identifiers. What will this mean for suppliers of medical technology and how will this be integrated into the proposed registration process for medical devices within the new Therapeutics Products legislation.

1400-1430
Proposed Use of Medical Device Terminology and Identifications Standards
Alastair Kenworthy, Technology & Digital Services, Ministry of Health, Wellington, NZ 


Therapeutic Products Regulation Workshop
The Ministry of Health's work on the development of the new regulatory scheme for therapeutic products is progressing steadily. This session will provide an opportunity to be updated on progress and to discuss the overall approach proposed for the regulation of medical devices.

1430-1525
Susan Martindale, Regulatory Policy, Strategy and Policy Business Unit, Ministry of Health, Wellington, NZ
Saerom Shin, Product Regulation, Medsafe, Ministry of Health, Wellington, NZ 


1525

MTANZ MedTech Forum Close

1530-1600

Afternoon Tea and Exhibitor Networking                                                                                                                                           Upper NZI

1600-1730            MTANZ AGM  (Members only)


1730-1830

Networking drinks with MedTech CoRE delegates

                                                               Lower NZI Foyer

 

 Please note this is a preliminary programme and is subject to change.